Aeroflex Enterprises Ltd
AEROENTERAeroflex Enterprises Ltd is coiled. The quarters are improving, yet the P/E sits at the 11th percentile of its own 9-year range — the business is moving before the market.
The sharpest disagreement: profits are rising, but only −20% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (13 weeks in) while the P/E sits at the 11th percentile of its own 9-year range. Underneath, the last four quarters read improving — profit +635.7% year on year, and −20% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Aeroflex Enterprises Ltd trades at ₹128, in a confirmed uptrend and 13 weeks into that stage. That is +25.6% against its own 200-day average. It sits at 84% of a 52-week range of ₹67 to ₹140. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 25 straight weeks.
Today the stock is in a confirmed uptrend — week 13 of stage 2, confirmed. At ₹128 it trades +25.6% versus its 200-day average and sits at 84% of its 52-week range (₹67–₹140).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +1,292% while the NIFTY 500 moved +278% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 25 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
Aeroflex Enterprises Ltd's story is not scored yet against the markers our research file set on 31 May 2026. Where it sits in its own cycle: Not stated in the research file. Our fortnightly research layers last read it on 19 July 2026.
Our read, 31 May 2026. A specialised hose exporter pivoting to AI data-centre thermal management — the skid assembly vertical is early-stage but the TAM is real and the core business is still accelerating.
What is proven. A specialised hose exporter pivoting to AI data-centre thermal management — the skid assembly vertical is early-stage but the TAM is real and the core business is still accelerating.
What is not proven yet. Design responsibility shift from principal to Aeroflex caused delivery of Rs 21.2 Cr vs Rs 45 Cr communicated pipeline per; execution of 15,000 TPM target and 60-75% utilisation by March 2027 remains unverified.
Layer 1 read, 19 July 2026 — KEEP. Cheap, compressing multiple on a genuinely accelerating exporter — but the cash isn't converting yet. Revenue climbed from Rs 134cr to Rs 200cr and quarterly profit from Rs 14cr to Rs 26cr in four quarters at a de-rated PE of ~20. The catch is that three years of profit have produced negative operating cash as working capital swells with the scale-up, and the exciting AI data-centre vertical is still tiny and has already been re-scoped once (Hydair expansion abandoned).
What would change Layer 1’s mind. A quarter where operating cash flow turns clearly positive as receivables/inventory normalize would push toward P1; continued WC bloat with OCF negative, or the skid/liquid-cooling vertical stalling (single-customer concentration), would break the accelerating-cheap-compounder case.
Layer 2 read, 19 July 2026 — BENCH. Real earnings acceleration, but three years of negative operating cash flow keeps it on the bench, not in the book. Profit is genuinely inflecting — margins climbed from 14% to 20% and quarterly profit rose from Rs 14cr to Rs 26cr through FY26. But over three years the company has produced negative Rs 88cr of operating cash against Rs 440cr of reported profit, working capital has ballooned to 203 days, and the May-2026 concall never addressed the cash gap. That is exactly the pattern the fund's Working Capital Growth Governor model says to bench, so it stays P2 without an ADVANCE.
What would change Layer 2’s mind. One-to-two clean quarters where operating cash flow tracks PAT (OCF/PAT toward ~1.0) as working-capital days normalise below ~160, with management explicitly explaining the inventory build reverses — that would flip BENCH to ADVANCE.
The test written in advance. Skid Assembly Design and Audit Bottleneck — Skid Assembly Design and Audit Bottleneck by the next result.
The test written in advance. Repeated Guidance Inconsistency Pattern — Repeated Guidance Inconsistency Pattern Any further undisclosed pivot or delivery shortfall within 2 quarters would require DROP review. by the next result.
The test written in advance. Single-Customer Concentration in Skid Vertical — Single-Customer Concentration in Skid Vertical by the next result.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| Data-Centre Liquid Cooling Skid Assembly… | HIGH | — | 617 units in 4 months generated Rs 21.2 Cr per; at 15,000 TPM × 75% utilisation × Rs 3-3.25 L ASP, the vertical targets Rs… | Monthly skid throughput below 60% of 15,000 TPM target by December 2026 would falsify the Rs 325-350 Cr revenue potential. |
| Core Hose Assembly Export Recovery | MEDIUM_HIGH | — | Base business ex-skids guided 15-20% FY27 growth per; US customer at 25-26% of sales continued growing in absolute terms per; EU… | Monthly skid throughput below 60% of 15,000 TPM target by December 2026 would falsify the Rs 325-350 Cr revenue potential. |
| Metal Bellows Scaling into High-Margin… | MEDIUM | — | FY26 Rs 8 Cr revenue; exit ARR Rs 12 Cr; peak potential Rs 80 Cr at 85% utilisation over 2-3 years per; identified as… | Monthly skid throughput below 60% of 15,000 TPM target by December 2026 would falsify the Rs 325-350 Cr revenue potential. |
Lever 1 · Operating leverage — BUILDING. 617 units in 4 months generated Rs 21.2 Cr per; at 15,000 TPM × 75% utilisation × Rs 3-3.25 L ASP, the vertical targets Rs 325-350 Cr per — vs FY26 consolidated revenue of Rs 698 Cr. What proves it keeps working: Data-Centre Liquid Cooling Skid Assembly Ramp. It stops working if Monthly skid throughput below 60% of 15,000 TPM target by December 2026 would falsify the Rs 325-350 Cr revenue potential.
Lever 2 · Value-added mix — BUILDING. Base business ex-skids guided 15-20% FY27 growth per; US customer at 25-26% of sales continued growing in absolute terms per; EU FTA removes competitive disadvantage vs Turkish manufacturers. What proves it keeps working: Core Hose Assembly Export Recovery. It stops working if Monthly skid throughput below 60% of 15,000 TPM target by December 2026 would falsify the Rs 325-350 Cr revenue potential.
Lever 4 · Paying down debt — BUILDING. FY26 Rs 8 Cr revenue; exit ARR Rs 12 Cr; peak potential Rs 80 Cr at 85% utilisation over 2-3 years per; identified as highest-margin segment with aerospace, AI infrastructure, data-centre applications. What proves it keeps working: Metal Bellows Scaling into High-Margin Applications. It stops working if Monthly skid throughput below 60% of 15,000 TPM target by December 2026 would falsify the Rs 325-350 Cr revenue potential.
Sources: our stock research file (31 May 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Aeroflex Enterprises Ltd reported ₹189 Cr of revenue in the Jun 26 quarter, +41.0% year on year. That is the 8th straight quarter of year-on-year growth. Over 10 years it has compounded at 22.5% a year. The last full year, FY26, came in at ₹698 Cr. The last four reported quarters add to ₹752 Cr.
FY26 revenue came in at ₹698 Cr (+20.8% on the year), capping 10 years at 22.5% compound. The latest quarter (Jun 26) printed ₹189 Cr, +41.0% year on year — the 8th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +27.9% growth against the decade's 22.5% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +27.5% over the last 4 quarters against +23.5%/yr over the last 8 — accelerating; TTM profit +126.0% vs −11.5%/yr — accelerating.
FY26-Q4. revenue ₹200 Cr and profit ₹26 Cr as reported.
FY27-Q1. revenue ₹189 Cr and profit ₹103 Cr as reported.
Why-sources: our stock research file (31 May 2026) and the company’s own results for those quarters.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Aeroflex Enterprises Ltd's operating margin is 9.0% in the Jun 26 quarter, −5.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −207.0% to 18.0%. The current quarter sits inside that band.
Why this happened. Aeroflex launched skid assembly supply for data-centre liquid cooling in Q3 FY26 through an exclusive domestic contract with a large US principal per. FY26 delivered 617 units and Rs 21.2 Cr per. Capacity scaled from 2,000 to 6,000 units and targets 15,000 TPM by Q1 FY27 with March 2027 month-end utilisation of 60-75% per. Design finalisation bottleneck (design responsibility shifted from principal to Aeroflex's internal team per) is the current pace constraint. Management expects resolution within coming months.
The latest quarter's operating margin is 9.0%, −5.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −207.0%–18.0%.
🚨 Why the margin moved: operating margin went −4.4 pp year on year while gross margin went +4.1 pp — the loss came mostly from the gross line: input costs and pricing.
FY26-Q4. revenue ₹200 Cr and profit ₹26 Cr as reported.
FY27-Q1. revenue ₹189 Cr and profit ₹103 Cr as reported.
Why-sources: our stock research file (31 May 2026) and the company’s own results for those quarters.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Aeroflex Enterprises Ltd earned ₹103 Cr of net profit in the Jun 26 quarter, +635.7% year on year. It is the 3rd consecutive quarter of growth. Full-year FY26 profit was ₹85.0 Cr. That is 54.5% of the quarter's revenue. The same quarter a year earlier earned ₹14.0 Cr.
Jun 26 profit was ₹103 Cr, +635.7% year on year — the 3rd consecutive quarter of growth. On the full year, FY26 printed ₹85.0 Cr (+4.9%).
Why profit moved: revenue contributed +41.0% and the margin −5.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +169.3% vs revenue +27.9%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
FY26-Q4. revenue ₹200 Cr and profit ₹26 Cr as reported.
FY27-Q1. revenue ₹189 Cr and profit ₹103 Cr as reported.
Why-sources: our stock research file (31 May 2026) and the company’s own results for those quarters.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −20% of Aeroflex Enterprises Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹18.0 Cr of operating cash against ₹85.0 Cr of profit. After ₹120 Cr of capital spending, ₹−102 Cr was left as free cash.
FY26: operating cash of ₹18.0 Cr against reported profit of ₹85.0 Cr, leaving free cash of ₹−102 Cr after ₹120 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −20% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −20%: the cash cycle stretched 84 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 84 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Aeroflex Enterprises Ltd's cash conversion cycle runs 166 days in FY26, up from 82 days in FY21. Capital spending ran ₹311 Cr over the last 3 years. At FY26 sales of ₹698 Cr each day of that cycle holds about ₹1.9 Cr, so roughly ₹317 Cr sits inside the business at any moment.
FY26: debtors at 112 days, inventory at 149 days — roughly 4.9 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 166 days, looser than FY21's 82.
The full loop: cash goes out to suppliers and production on day 0; stock waits 149 days to sell; customers pay about 112 days after that; and suppliers themselves are paid at 95 days — netting out to the 166-day cycle.
In money terms: at FY26 sales of ₹698 Cr, each day of the cycle holds about ₹1.9 Cr — so the 166-day loop keeps roughly ₹317 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹311 Cr over the last 3 fiscal years against ₹57.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹23.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Aeroflex Enterprises Ltd earns a ROCE of 13% in FY26. That is up from a trough of −86% in FY15. Return on invested capital clears the cost of that capital by −0.8 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 12.2% net margin on 0.60× asset turns.
FY26 ROCE is 13%, recovered from a FY15 trough of −86% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 12.2% net margin × 0.60× asset turns × 1.40× balance-sheet leverage ≈ 10.2% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 11.2% − 12.0% = a −0.8 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Aeroflex Enterprises Ltd carries total debt of ₹41.0 Cr against shareholder equity of ₹962 Cr as of Mar 26, a debt-to-equity of 0.04 — effectively unlevered. On the annual view that ratio went from 0.43 in FY22 to 0.04 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Why this happened. Metal bellows generated Rs 8 Cr in FY26 per, targeting 50-60% capacity utilisation over next 2-3 years per. Margins are the highest in the portfolio per. Large OEM inquiries in pipeline. Bellows capex was rationalised from Rs 23 Cr to Rs 7.5 Cr to reduce gestation risk per.
Mar 26: total debt of ₹41.0 Cr against shareholder equity of ₹962 Cr — a debt-to-equity of 0.04. On the annual view, debt-to-equity went from 0.43 (FY22) to 0.04 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Aeroflex Enterprises Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.1 points over the same window, to 1.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +0.7 points over 8 quarters to 52.3%; Foreign institutions: +0.1 points over 8 quarters to 1.3%; Domestic institutions: −0.1 points over 8 quarters to 0.1%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Aeroflex Enterprises Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Aeroflex Enterprises Ltd trades at 9.5× P/E, near the bottom of its own range — cheaper only 11% of the time. Its long-run median P/E is 20.4×, measured across 9.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 9.5× is near the bottom of its own range — cheaper only 11% of the time, against a long-run median of 20.4× measured over 9.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +20.9% against a +35.4% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +31.3%/yr price move, ~+54.7%/yr came from earnings growth and ~−23.4 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Aeroflex Enterprises Ltd reads as improving on its fundamental arc. Improving — EPS growth bottomed 7 quarters ago at −82.3% and has held its recovery at +200.7%, ROCE slipping at 13.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +20.8% | +14.4% | +27.8% | +22.5% |
| Profit | +4.9% | +23.6% | +56.7% | — |
| EPS | +20.9% | +14.5% | +48.7% | — |
| Share price | +35.4% | +1.9% | +31.3% | +25.6% |
4-Factor Sector Score
62.5/100 — rank 5 of 36 in Miscellaneous · 87% evidence confidence
Aeroflex Enterprises Ltd scores 62.5 out of 100 against the 36 companies it is compared with in Miscellaneous, ranking 5. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 19.7 + 14.7 + 8.9 + 19.2 = 62.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Said versus delivered
What Aeroflex Enterprises Ltd's management promised, set against what actually arrived — 4 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.
Hydair Capacity Expansion Plans Silently Abandoned · 6 May 2026. In both prior calls, management explicitly committed to an imminent Hydair capacity expansion announcement, stating in Oct 2025 it would come very soon and in Jan 2026 that details would be shared in due course of time. In the May 2026 call, when the same analyst directly asked whether any capex was planned for Hydair, management gave no mention of expansion and instead repositioned Hydair entirely as an internal manufacturing unit, while Hydair utilization simultaneously declined from approximately 70% in Jan 2026 to 60% in May 2026, contradicting the external scaling narrative maintained across both prior calls.
🚨 Skid Assembly Execution Bottleneck Not Previously Disclosed · 6 May 2026. In the Jan 2026 call, management presented an INR45 crore near-term skid assembly pipeline as already committed and scheduled for dispatch by the principal partner, with no mention of any design dependency or operational risk that could impede execution. The May 2026 call revealed a previously undisclosed structural bottleneck - that design responsibility originally held by the principal had shifted to Aeroflex's internal team - causing material execution delays. Actual skid sales over the four months of operation totaled only approximately INR21.2 crores, well below the INR45 crore pipeline presented in Jan 2026 as ready for scheduled execution.
🚨 Skid Assembly Margin Characterization Downgraded Without Explanation · 6 May 2026. In the Jan 2026 call, management explicitly described skid assembly margins as better than hose margins and in line with the higher-margin assemblies segment, placing them above the overall company average. In the May 2026 call, without any explanation, the same margins are characterized only as being in line with the average margins of the company - a meaningful step down since the company average is pulled down by lower-margin hose products. Given that management is guiding skid assemblies to scale from 5% of FY26 revenue to 20-22% of FY27 revenue, this unexplained repositioning of margin expectations has a direct and material impact on forward earnings projections.
Capex and Capacity Rationalization · 29 January 2026. In the October 2025 call, management confirmed the expansion for miniature metal bellows was ongoing with a planned capex of INR 23 crores and capacity of 240,000 pieces. However, in the January 2026 call, they abruptly slashed this plan, revising the outlay down to INR 7.5 crores and capacity to 60,000 pieces (a 75% reduction), citing a need to reduce gestation risk. Earlier call (Oct 2025): “The planned capex... was INR23 crores for the miniature metal bellows... The miniature one that we are doing is about 240,000 pieces per annum. We are ongoing with our expansion.” Later call (Jan 2026): “We have decided to rationalize the capital expenditure for the miniature metal bellows project. The planned outlay has been revised from 23 crores to 7.5 crores... capacity... revised from 240,000 pieces per annum to 60,000 pieces per annum.”
Every quote above is taken word for word from the company’s own earnings calls.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Gulshan Polyols LtdGULPOLY | 74.3/100Favorable setup87% evidence | ASLEEP | 27.5/35 Revenue 9.4% · PAT 100% · OPM change 7 pp 95% evidence | 19.1/25 ROCE 18.3% · OPM 13% 95% evidence | 13.1/20 P/E 8× · PEG — 50% evidence | 14.6/20 RS sector 13.6% · RS bench 12.7% · 1Y 8.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 27.5 + 19.1 + 13.1 + 14.6 = 74.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Sagility LtdSAGILITY | 66.2/100Favorable setup87% evidence | BASING | 24.7/35 Revenue 29.4% · PAT 49.3% · OPM change 0 pp 100% evidence | 15.8/25 ROCE 13.4% · OPM 22% 100% evidence | 13.9/20 P/E 19.3× · PEG 1.02 65% evidence | 11.8/20 RS sector 7.2% · RS bench -7.7% · 1Y -6.4%0 of 10 weeks ahead 70% evidence |
| Exact sum: 24.7 + 15.8 + 13.9 + 11.8 = 66.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3IIRM Holdings India Ltd526530 | 64.4/100Mixed-positive evidence75% evidence | LEADER | 16.3/35 Revenue 14.9% · PAT 12.7% · OPM change 1.1 pp 95% evidence | 19.0/25 ROCE 20.4% · OPM 24.6% 76% evidence | 9.8/20 P/E 37.2× · PEG — 15% evidence | 19.3/20 RS sector 40% · RS bench 38.6% · 1Y 71.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 19 + 9.8 + 19.3 = 64.4 · Decision use: Price leads the evidence: RS versus the benchmark is 38.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4Exhicon Events Media Solutions Ltd543895 | 63.4/100Thin evidence · provisional60% evidence | ASLEEP | 19.0/35 Revenue 100% · PAT 100% · OPM change 0 pp 48% evidence | 20.1/25 ROCE 29.5% · OPM 28% 76% evidence | 13.2/20 P/E 18.8× · PEG — 50% evidence | 11.1/20 RS sector 2.2% · RS bench -3.2% · 1Y -4.9%0 of 10 weeks ahead 70% evidence |
| Exact sum: 19 + 20.1 + 13.2 + 11.1 = 63.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Aeroflex Enterprises Ltdthis pageAEROENTER | 62.5/100Mixed-positive evidence87% evidence | LEADER | 19.7/35 Revenue 27.5% · PAT 100% · OPM change -5 pp 95% evidence | 14.7/25 ROCE 12.6% · OPM 9% 95% evidence | 8.9/20 P/E 9.5× · PEG — 50% evidence | 19.2/20 RS sector 36.3% · RS bench 34.8% · 1Y 32.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 14.7 + 8.9 + 19.2 = 62.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Take Solutions LtdTAKE | 58.7/100Thin evidence · provisional57% evidence | 24.7/35 Revenue — · PAT 100% · OPM change 2932.2 pp 57% evidence | 8.5/25 ROCE 11.2% · OPM — 80% evidence | 8.5/20 P/E 3222× · PEG — 15% evidence | 17.0/20 RS sector 71.1% · RS bench 71.4% · 1Y 384%11 of 12 weeks ahead to 2026-05-03 70% evidence | |
| Exact sum: 24.7 + 8.5 + 8.5 + 17 = 58.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Global Education LtdGLOBAL | 57.8/100Mixed-positive evidence80% evidence | ASLEEP | 14.2/35 Revenue 28.2% · PAT 3.3% · OPM change 0.3 pp 95% evidence | 19.8/25 ROCE 29.2% · OPM 41% 95% evidence | 10.3/20 P/E 20.8× · PEG — 15% evidence | 13.5/20 RS sector 16.7% · RS bench 16% · 1Y 63%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.2 + 19.8 + 10.3 + 13.5 = 57.8 · Decision use: Price leads the evidence: RS versus the benchmark is 16%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 8GMR Airports LtdGMRAIRPORT | 56.6/100Mixed-positive evidence74% evidence | FADING | 22.7/35 Revenue 38.8% · PAT 100% · OPM change 1 pp 74% evidence | 11.3/25 ROCE 11.6% · OPM 37% 100% evidence | 8.7/20 P/E 191× · PEG — 15% evidence | 13.9/20 RS sector 2.6% · RS bench 1.9% · 1Y 14.3%8 of 12 weeks ahead 100% evidence |
| Exact sum: 22.7 + 11.3 + 8.7 + 13.9 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9R K Swamy LtdRKSWAMY | 56.5/100Mixed-positive evidence65% evidence | FADING | 22.5/35 Revenue 14.3% · PAT 17.3% · OPM change 2.6 pp 95% evidence | 15.3/25 ROCE 12.3% · OPM 10.4% 95% evidence | 10.4/20 P/E 19.5× · PEG — 15% evidence | 8.3/20 RS sector — · RS bench -16.7% · 1Y —4 of 5 weeks ahead 25% evidence |
| Exact sum: 22.5 + 15.3 + 10.4 + 8.3 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Aegis Vopak Terminals LtdAEGISVOPAK | 56.1/100Mixed-positive evidence60% evidence | BREAKING OUT | 21.9/35 Revenue 25.9% · PAT 40.9% · OPM change 2 pp 95% evidence | 13.2/25 ROCE 7.6% · OPM 77% 76% evidence | 9.2/20 P/E 110× · PEG — 15% evidence | 11.8/20 RS sector — · RS bench 12% · 1Y 9%7 of 10 weeks ahead 25% evidence |
| Exact sum: 21.9 + 13.2 + 9.2 + 11.8 = 56.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Inox Green Energy Services LtdINOXGREEN | 54.1/100Mixed-positive evidence75% evidence | FADING | 22.2/35 Revenue 16.5% · PAT 100% · OPM change -13.2 pp 95% evidence | 9.1/25 ROCE 8.4% · OPM -2.2% 76% evidence | 9.6/20 P/E 61.3× · PEG — 15% evidence | 13.2/20 RS sector 0.5% · RS bench -0.3% · 1Y 24.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 22.2 + 9.1 + 9.6 + 13.2 = 54.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Parin Enterprises LtdPARIN | 53.7/100Mixed-positive evidence63% evidence | BREAKING OUT | 19.4/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence | 11.6/25 ROCE 10.8% · OPM 9% 95% evidence | 8.8/20 P/E 124× · PEG — 15% evidence | 13.9/20 RS sector 15.7% · RS bench 15% · 1Y 76.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 19.4 + 11.6 + 8.8 + 13.9 = 53.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Anzen India Energy Yield Plus TrustANZEN | 50.5/100Mixed-positive evidence60% evidence | FADING | 20.7/35 Revenue 100% · PAT 100% · OPM change -9 pp 95% evidence | 9.1/25 ROCE 3.3% · OPM 80% 76% evidence | 9.3/20 P/E 102× · PEG — 15% evidence | 11.4/20 RS sector — · RS bench 7.3% · 1Y 14.1%2 of 10 weeks ahead 25% evidence |
| Exact sum: 20.7 + 9.1 + 9.3 + 11.4 = 50.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Eveready Industries India LtdEVEREADY | 50.1/100Mixed-positive evidence94% evidence | TURNING | 18.9/35 Revenue 8.7% · PAT 100% · OPM change 1 pp 100% evidence | 13.6/25 ROCE 17.2% · OPM 15% 100% evidence | 8.8/20 P/E 16.3× · PEG 2.1 100% evidence | 8.8/20 RS sector -9.5% · RS bench 1% · 1Y -12.8%5 of 10 weeks ahead 70% evidence |
| Exact sum: 18.9 + 13.6 + 8.8 + 8.8 = 50.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Jai Corp LtdJAICORPLTD | 49.8/100Mixed-negative evidence74% evidence | ASLEEP | 19.6/35 Revenue 2.7% · PAT -40.4% · OPM change 9 pp 95% evidence | 12.7/25 ROCE 13.3% · OPM 15% 95% evidence | 10.8/20 P/E 18.7× · PEG — 15% evidence | 6.7/20 RS sector -8.2% · RS bench -20% · 1Y -6.5%4 of 10 weeks ahead 70% evidence |
| Exact sum: 19.6 + 12.7 + 10.8 + 6.7 = 49.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16TCC Concept LtdTCC | 47.2/100Mixed-negative evidence81% evidence | ASLEEP | 16.6/35 Revenue 100% · PAT 51.1% · OPM change -45 pp 95% evidence | 11.8/25 ROCE 5.7% · OPM 36% 95% evidence | 14.3/20 P/E 18.7× · PEG — 50% evidence | 4.5/20 RS sector -17.6% · RS bench -40.7% · 1Y -48.8%0 of 11 weeks ahead 70% evidence |
| Exact sum: 16.6 + 11.8 + 14.3 + 4.5 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Jindal Photo LtdJINDALPHOT | 46.6/100Mixed-negative evidence77% evidence | ASLEEP | 20.4/35 Revenue 100% · PAT -80% · OPM change 15 pp 95% evidence | 10.1/25 ROCE -1.4% · OPM 98% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.1/20 RS sector -14.8% · RS bench -15.1% · 1Y 26.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 10.1 + 10 + 6.1 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Aqylon Nexus LtdAQYLON | 45.9/100Mixed-negative evidence72% evidence | ASLEEP | 18.5/35 Revenue 100% · PAT 100% · OPM change 2358 pp 71% evidence | 18.8/25 ROCE 131% · OPM 58% 95% evidence | 8.6/20 P/E 819× · PEG — 15% evidence | 0.0/20 RS sector -76% · RS bench -76% · 1Y -80.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.5 + 18.8 + 8.6 + 0 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Shipping Corporation of India Land & Assets LtdSCILAL | 42.9/100Mixed-negative evidence80% evidence | ASLEEP | 24.2/35 Revenue 23.8% · PAT 100% · OPM change 13 pp 95% evidence | 5.0/25 ROCE 1.3% · OPM -14% 95% evidence | 9.4/20 P/E 65.9× · PEG — 15% evidence | 4.3/20 RS sector -13.8% · RS bench -14.3% · 1Y -17.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 24.2 + 5 + 9.4 + 4.3 = 42.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -13.8% and the one-year return is -17.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 20TruAlt Bioenergy LtdTRUALT | 40.1/100Mixed-negative evidence63% evidence | TURNING | 10.7/35 Revenue 1.8% · PAT -8.1% · OPM change 7 pp 100% evidence | 9.3/25 ROCE 10.4% · OPM 21% 100% evidence | 10.1/20 P/E 26.4× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —6 of 12 weeks ahead 0% evidence |
| Exact sum: 10.7 + 9.3 + 10.1 + 10 = 40.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21GKW LtdGKWLIMITED | 39.2/100Mixed-negative evidence71% evidence | ASLEEP | 10.9/35 Revenue -13.5% · PAT 0% · OPM change -2 pp 95% evidence | 9.2/25 ROCE 0.5% · OPM 84% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.1/20 RS sector -0.9% · RS bench -6.6% · 1Y -2.4%3 of 10 weeks ahead 70% evidence |
| Exact sum: 10.9 + 9.2 + 10 + 9.1 = 39.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Unitech LtdUNITECH | 36.3/100Mixed-negative evidence69% evidence | ASLEEP | 18.0/35 Revenue 45.3% · PAT -10% · OPM change 15 pp 71% evidence | 3.5/25 ROCE 0.1% · OPM 6% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.8/20 RS sector -28.9% · RS bench -29.3% · 1Y -42.7%3 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 3.5 + 10 + 4.8 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Kaveri Seed Company LtdKSCL | 36.0/100Mixed-negative evidence94% evidence | ASLEEP | 11.3/35 Revenue 1.4% · PAT -21.7% · OPM change 1 pp 100% evidence | 14.4/25 ROCE 18.8% · OPM 40% 100% evidence | 4.9/20 P/E 16.1× · PEG 3.12 100% evidence | 5.4/20 RS sector -17.2% · RS bench -18.3% · 1Y -27.6%3 of 11 weeks ahead 70% evidence |
| Exact sum: 11.3 + 14.4 + 4.9 + 5.4 = 36 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Delta Corp LtdDELTACORP | 35.5/100Mixed-negative evidence81% evidence | ASLEEP | 9.7/35 Revenue -9.3% · PAT -80% · OPM change -3 pp 95% evidence | 8.6/25 ROCE 5% · OPM 18% 95% evidence | 11.9/20 P/E 10.5× · PEG — 50% evidence | 5.3/20 RS sector -18.1% · RS bench -14.3% · 1Y -26.9%5 of 10 weeks ahead 70% evidence |
| Exact sum: 9.7 + 8.6 + 11.9 + 5.3 = 35.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Prozone Realty LtdPROZONER | 34.7/100Adverse evidence80% evidence | ASLEEP | 17.0/35 Revenue -9.9% · PAT 100% · OPM change 8.2 pp 95% evidence | 6.4/25 ROCE -1% · OPM -35.6% 95% evidence | 9.5/20 P/E 62.1× · PEG — 15% evidence | 1.8/20 RS sector -19.6% · RS bench -20% · 1Y -3.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 6.4 + 9.5 + 1.8 = 34.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Stanley Lifestyles LtdSTANLEY | 29.9/100Adverse evidence74% evidence | ASLEEP | 6.6/35 Revenue -5.6% · PAT -80% · OPM change -3.4 pp 95% evidence | 10.8/25 ROCE 6.4% · OPM 17.3% 95% evidence | 9.1/20 P/E 113× · PEG — 15% evidence | 3.4/20 RS sector -43.7% · RS bench -32% · 1Y -56.2%3 of 10 weeks ahead 70% evidence |
| Exact sum: 6.6 + 10.8 + 9.1 + 3.4 = 29.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Embassy Developments LtdEMBDL | 28.1/100Adverse evidence64% evidence | ASLEEP | 5.9/35 Revenue -46.6% · PAT -80% · OPM change -58.4 pp 71% evidence | 3.4/25 ROCE -2.4% · OPM -60% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.8/20 RS sector -12% · RS bench -12.7% · 1Y -35.7%7 of 12 weeks ahead 100% evidence |
| Exact sum: 5.9 + 3.4 + 10 + 8.8 = 28.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28RattanIndia Enterprises LtdRTNINDIA | 17.6/100Adverse evidence74% evidence | ASLEEP | 2.7/35 Revenue 2.1% · PAT -80% · OPM change -23.9 pp 100% evidence | 1.0/25 ROCE -4.8% · OPM 2.1% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.9/20 RS sector -32.1% · RS bench -25.1% · 1Y -41.7%5 of 10 weeks ahead 70% evidence |
| Exact sum: 2.7 + 1 + 10 + 3.9 = 17.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Central Mine Planning & Design Institute LtdCMPDI | 62.4/100Thin evidence · provisional38% evidence | ASLEEP | 22.1/35 Revenue — · PAT — · OPM change 8 pp 32% evidence | 20.1/25 ROCE 38.1% · OPM 30% 95% evidence | 10.2/20 P/E 25.9× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 5 weeks ahead 0% evidence |
| Exact sum: 22.1 + 20.1 + 10.2 + 10 = 62.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30FlySBS Aviation LtdFLYSBS | 54.8/100Thin evidence · provisional41% evidence | TURNING | 15.4/35 Revenue — · PAT — · OPM change -8 pp 26% evidence | 19.4/25 ROCE 32.5% · OPM 21% 95% evidence | 11.2/20 P/E 12.6× · PEG — 15% evidence | 8.8/20 RS sector — · RS bench -12.2% · 1Y -1.6%3 of 10 weeks ahead 25% evidence |
| Exact sum: 15.4 + 19.4 + 11.2 + 8.8 = 54.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 31Qualitek Labs Ltd544091 | 53.5/100Thin evidence · provisional29% evidence | TURNING | 17.3/35 Revenue — · PAT — · OPM change -3 pp 7% evidence | 14.8/25 ROCE 11.9% · OPM 26% 76% evidence | 9.9/20 P/E 34× · PEG — 15% evidence | 11.5/20 RS sector — · RS bench 8.5% · 1Y —2 of 2 weeks ahead 25% evidence |
| Exact sum: 17.3 + 14.8 + 9.9 + 11.5 = 53.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 32Shree Vasu Logistics LtdSVLL | 52.0/100Thin evidence · provisional50% evidence | BREAKING OUT | 18.3/35 Revenue — · PAT — · OPM change 0.8 pp 26% evidence | 15.8/25 ROCE 12.9% · OPM 25.8% 95% evidence | 8.9/20 P/E 121× · PEG — 15% evidence | 9.0/20 RS sector -16.1% · RS bench 9.8% · 1Y -4.4%10 of 10 weeks ahead 70% evidence |
| Exact sum: 18.3 + 15.8 + 8.9 + 9 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 33Maagh Advertising & Marketing Services Ltd543624 | 49.8/100Thin evidence · provisional35% evidence | 18.4/35 Revenue — · PAT — · OPM change 275.6 pp 32% evidence | 9.1/25 ROCE -0.4% · OPM 55.6% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.3/20 RS sector — · RS bench 37% · 1Y —7 of 9 weeks ahead to 2025-03-19 25% evidence | |
| Exact sum: 18.4 + 9.1 + 10 + 12.3 = 49.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 34Indiqube Spaces LtdINDIQUBE | 47.3/100Thin evidence · provisional49% evidence | TURNING | 18.9/35 Revenue 38.9% · PAT 30.4% · OPM change 0 pp 71% evidence | 9.3/25 ROCE 6.4% · OPM 61% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.1/20 RS sector — · RS bench -6.3% · 1Y -16.7%2 of 10 weeks ahead 25% evidence |
| Exact sum: 18.9 + 9.3 + 10 + 9.1 = 47.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 35Tandhan Industries Ltd512062 | 46.6/100Thin evidence · provisional33% evidence | BREAKING OUT | 20.2/35 Revenue — · PAT 100% · OPM change — 33% evidence | 6.7/25 ROCE -0.3% · OPM 15.8% 76% evidence | 9.7/20 P/E 60.6× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —6 of 6 weeks ahead 0% evidence |
| Exact sum: 20.2 + 6.7 + 9.7 + 10 = 46.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 36Shree Rama Newsprint LtdRAMANEWS | 45.0/100Thin evidence · provisional46% evidence | 14.1/35 Revenue -20% · PAT 69.8% · OPM change -8 pp 40% evidence | 6.1/25 ROCE 1.9% · OPM 8% 71% evidence | 10.0/20 P/E — · PEG — 0% evidence | 14.8/20 RS sector 9.7% · RS bench 10.5% · 1Y 9.2%11 of 12 weeks ahead to 2026-04-19 70% evidence | |
| Exact sum: 14.1 + 6.1 + 10 + 14.8 = 45 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Aeroflex Enterprises Ltd's share price today?
Aeroflex Enterprises Ltd trades at ₹128, +35.4% over the past year. The company is valued at ₹1,448 Cr. The stock sits at 84% of its 52-week range of ₹67–₹140, +25.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 13 weeks in. — as of 14 August 2026.
What were Aeroflex Enterprises Ltd's latest quarterly results?
Aeroflex Enterprises Ltd reported revenue of ₹189 Cr and net profit of ₹103 Cr for the Jun 26 quarter. Revenue rose 41.0% and profit rose 635.7% year on year. Earnings per share were ₹8.54. The operating margin was 9.0%, 5.0 pp lower than a year earlier. — as of 14 August 2026.
What is Aeroflex Enterprises Ltd's revenue?
Aeroflex Enterprises Ltd reported revenue of ₹189 Cr in the Jun 26 quarter, +41.0% year on year. For the full FY26 fiscal year, revenue was ₹698 Cr (+20.8%). Over the last 10 years revenue compounded at 22.5% a year. — as of 14 August 2026.
What is Aeroflex Enterprises Ltd's profit?
Aeroflex Enterprises Ltd earned ₹103 Cr of net profit in the Jun 26 quarter, +635.7% year on year — the 3rd straight quarter of growth. Full-year FY26 profit was ₹85.0 Cr. The operating margin ran 9.0% in the latest quarter. — as of 14 August 2026.
What is Aeroflex Enterprises Ltd's market cap?
Aeroflex Enterprises Ltd's market capitalisation is ₹1,448 Cr at a share price of ₹128. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is Aeroflex Enterprises Ltd's P/E ratio?
Aeroflex Enterprises Ltd trades at a P/E of 9.5×, at the 11th percentile of its own 9-year range, against a long-run median of 20.4×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does Aeroflex Enterprises Ltd pay a dividend?
Not in its latest year — Aeroflex Enterprises Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 7 of its last 13 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 14 August 2026.
Is Aeroflex Enterprises Ltd overvalued?
On its own history, Aeroflex Enterprises Ltd looks cheap: its P/E of 9.5× has been cheaper only 11% of the time in 9 years (long-run median 20.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.
Is Aeroflex Enterprises Ltd growing?
Yes — Aeroflex Enterprises Ltd is growing: latest-quarter revenue +41.0% year on year, profit +635.7%, and the margin −5.0 pp at 9.0%. The earnings engine currently reads: improving — as of 14 August 2026.
How is Aeroflex Enterprises Ltd performing?
Aeroflex Enterprises Ltd is in a confirmed uptrend, 13 weeks in. Its latest quarter's revenue rose 41.0% and profit rose 635.7% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 25 weeks. This describes what the data did, not a rating. — as of 14 August 2026.
What stage is Aeroflex Enterprises Ltd in?
Improving — EPS growth bottomed 7 quarters ago at −82.3% and has held its recovery at +200.7%, ROCE slipping at 13.0%. The read comes from the last 12 quarters of growth (revenue growth +27.5% latest, profit growth +126.0% latest, eps growth +200.7% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 14 August 2026.
Is Aeroflex Enterprises Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 13 of stage 2), trading +25.6% versus its 200-day average and at 84% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Is Aeroflex Enterprises Ltd beating the market?
On recent form, yes — Aeroflex Enterprises Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 25 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +1,292% against the NIFTY 500's +278% — ahead of the index over the full window. — as of 14 August 2026.
Will Aeroflex Enterprises Ltd's share price go up?
This page publishes no price forecast for Aeroflex Enterprises Ltd. What it measures instead: the share price is ₹128, the price is in a confirmed uptrend 13 weeks in. Its P/E of 9.5× sits at the 11th percentile of its own 9-year range. — as of 14 August 2026.
Who owns Aeroflex Enterprises Ltd?
Promoters hold 52.3% of Aeroflex Enterprises Ltd, foreign institutions 1.3%, domestic institutions 0.1% and the public 46.4% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 14 August 2026.
Does Aeroflex Enterprises Ltd have too much debt?
No — Aeroflex Enterprises Ltd's debt-to-equity is 0.05, and operating profit covers the interest bill 24×. FY26 borrowings were ₹41.0 Cr against equity of ₹827 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.
What is Aeroflex Enterprises Ltd's capex?
Aeroflex Enterprises Ltd spent ₹311 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹120 Cr, with ₹23.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.
What is Aeroflex Enterprises Ltd's cash flow?
Aeroflex Enterprises Ltd generated ₹18.0 Cr of operating cash flow in FY26 and ₹−102 Cr of free cash flow after ₹120 Cr of capital spending. Reported profit that year was ₹85.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 14 August 2026.
Is Aeroflex Enterprises Ltd's profit real cash?
No — operating cash was negative over the last 3 fiscal years: Aeroflex Enterprises Ltd consumed cash while reporting profit. In FY26, operating cash was ₹18.0 Cr against reported profit of ₹85.0 Cr. Cash-flow resolution is annual — as of 14 August 2026.
Where is Aeroflex Enterprises Ltd in its business cycle?
Aeroflex Enterprises Ltd's FY26 operating margin was 17.0%, against a 13-year band of −207.0%–18.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 9.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What could break the Aeroflex Enterprises Ltd story?
The sharpest disagreement: profits are rising, but only −20% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is Aeroflex Enterprises Ltd a stock worth studying right now?
This is not investment advice. The machine read: Aeroflex Enterprises Ltd is coiled. The quarters are improving, yet the P/E sits at the 11th percentile of its own 9-year range — the business is moving before the market. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.